BEAM

Beam Therapeutics (BEAM)

Beam Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BEAM

<< 이전 1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/01/09	21:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/01/09	20:30	GlobeNewswire Inc.	Beam Therapeutics Reports Progress Across Base Editing Portfolio and Outlines Key Anticipated Milestones	NASDAQ:BEAM	Beam Therapeutics Inc
2023/01/06	06:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/01/04	06:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/01/03	20:30	GlobeNewswire Inc.	Beam Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference	NASDAQ:BEAM	Beam Therapeutics Inc
2022/12/21	06:06	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/12/11	00:00	GlobeNewswire Inc.	Beam Therapeutics Presents First In Vivo Proof of Concept Preclinical Data on Multiplex Base Edited ESCAPE Platform for Non-Genotoxic Conditioning Regimen for Patients with Sickle Cell Disease Ahead of Autologous Transplant	NASDAQ:BEAM	Beam Therapeutics Inc
2022/12/03	04:00	GlobeNewswire Inc.	Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022	NASDAQ:BEAM	Beam Therapeutics Inc
2022/12/02	21:10	Dow Jones News	Beam Therapeutics Says FDA Lifts Clinical Hold on IND Application for BEAM-201	NASDAQ:BEAM	Beam Therapeutics Inc
2022/12/02	20:30	GlobeNewswire Inc.	Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/30	20:30	GlobeNewswire Inc.	Beam Therapeutics to Participate in the BofA Securities 2022 Virtual Biotech SMID Cap Conference	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/14	20:30	GlobeNewswire Inc.	Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/09	20:30	GlobeNewswire Inc.	Beam Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/07	21:36	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/07	21:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/07	20:30	GlobeNewswire Inc.	Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/03	22:01	GlobeNewswire Inc.	Beam Therapeutics to Present New Preclinical Data Highlighting Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant at the 64th ASH Annual Meeting	NASDAQ:BEAM	Beam Therapeutics Inc
2022/11/03	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/09/19	19:30	GlobeNewswire Inc.	Beam Therapeutics Presents First In Vivo Data Demonstrating Potential of Multiplex Base Editing Approach to Target Disease Drivers of Chronic Hepatitis B Infection	NASDAQ:BEAM	Beam Therapeutics Inc
2022/09/07	19:47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/09/03	05:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/09/03	05:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/09/03	05:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/09/01	19:30	GlobeNewswire Inc.	Beam Therapeutics to Participate at the Wells Fargo 2022 Healthcare Conference	NASDAQ:BEAM	Beam Therapeutics Inc
2022/08/30	21:17	Dow Jones News	Beam Therapeutics Gets Details of FDA Hold on BEAM-201 Studies	NASDAQ:BEAM	Beam Therapeutics Inc
2022/08/30	20:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/08/11	23:01	GlobeNewswire Inc.	ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox	NASDAQ:BEAM	Beam Therapeutics Inc
2022/08/09	20:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/08/09	20:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BEAM	Beam Therapeutics Inc
2022/08/09	19:30	GlobeNewswire Inc.	Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results	NASDAQ:BEAM	Beam Therapeutics Inc